Literature DB >> 26686872

Salvage abdominoperineal excisions in recurrent anal cancer--impact of different reconstruction techniques on outcome, morbidity, and complication rates.

Sabine Hannes1, Alexander Reinisch1, Wolf O Bechstein1, Nils Habbe2.   

Abstract

BACKGROUND: Squamous cell cancer of the anus (SCCA) is a rare disease of the gastrointestinal tract. Even though chemoradiation therapy is the treatment of choice, a substantial number of patients develop recurrent cancers or present with persisting SCCA. Therefore, abdominoperineal excisions as a salvage therapy are the only chance of cure. PATIENTS AND METHODS: Hospital files of all patients with recurrent squamous cell carcinoma of the anus who underwent abdominoperineal excision performed at the Department of General and Visceral Surgery of the University Hospital Frankfurt between January 2003 and December 2013 were retrospectively reviewed.
RESULTS: Fourteen (nine males, five females) patients underwent abdominoperineal resections for recurrent SCCA. In six patients, the pelvic floor was closed by direct suture, four patients underwent reconstruction using a vertical rectus abdominis myocutaneous (VRAM) flap, and four patients received a gluteal myocutaneous flap. Patients receiving flap-mediated closure revealed a median hospital stay of 26 days (range 13-60 days) compared to 11 days (range 9-30 days) in patients with direct closure (p = 0.01). Two patients (14%) suffered from wound infections (Dindo-Clavien II), whereas three patients (21%) underwent up to seven reoperations for breakdown of their wounds and/or laparotomies (Dindo-Clavien IIIb). The calculated 5-year survival rate was 86%. Patients with rpT0/T1 stage had a significantly longer survival compared to patients presenting with rpT2/T3/T4 tumors.
CONCLUSION: Abdominoperineal excisions in patients with recurrent SCCA can provide long-term local control and survival. The complication rate is not associated with the closure technique employed, but patients undergoing flap-mediated closure revealed a significantly longer hospital stay.

Entities:  

Keywords:  APE; Abdominalperineal excision; Anal cancer; ELAPE; Salvage surgery

Mesh:

Year:  2015        PMID: 26686872     DOI: 10.1007/s00384-015-2474-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  27 in total

1.  Short-term outcome after gluteus maximus myocutaneous flap reconstruction of the pelvic floor following extra-levator abdominoperineal excision of the rectum.

Authors:  C Anderin; A Martling; J Lagergren; A Ljung; T Holm
Journal:  Colorectal Dis       Date:  2012-09       Impact factor: 3.788

2.  Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy.

Authors:  Christopher L Hallemeier; Y Nancy You; David W Larson; Eric J Dozois; Heidi Nelson; Kristi A Klein; Robert C Miller; Michael G Haddock
Journal:  Dis Colon Rectum       Date:  2014-04       Impact factor: 4.585

3.  Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer.

Authors:  T Holm; A Ljung; T Häggmark; G Jurell; J Lagergren
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

4.  The extended deep inferior epigastric flap: a clinical technique.

Authors:  G I Taylor; R Corlett; J B Boyd
Journal:  Plast Reconstr Surg       Date:  1983-12       Impact factor: 4.730

5.  Cure of chronic perineal sinus with gluteus maximus flap.

Authors:  A Shaw; J W Futrell
Journal:  Surg Gynecol Obstet       Date:  1978-09

6.  Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

Authors:  R Glynne-Jones; P J Nilsson; C Aschele; V Goh; D Peiffert; A Cervantes; D Arnold
Journal:  Eur J Surg Oncol       Date:  2014-10       Impact factor: 4.424

7.  Primary rectus abdominis myocutaneous flap for repair of perineal and vaginal defects after extended abdominoperineal resection.

Authors:  S W Bell; N Dehni; M Chaouat; J C Lifante; R Parc; E Tiret
Journal:  Br J Surg       Date:  2005-04       Impact factor: 6.939

8.  Abdominoperineal resection for anal cancer.

Authors:  P Mariani; A Ghanneme; A De la Rochefordière; J Girodet; M C Falcou; R J Salmon
Journal:  Dis Colon Rectum       Date:  2008-06-03       Impact factor: 4.585

9.  Salvage abdominoperineal resection for anal cancer following chemoradiation: a proposed scoring system for predicting postoperative survival.

Authors:  Jose Humberto S Correa; Leonaldson S Castro; Rubens Kesley; Jurandir A Dias; Jose Paulo Jesus; Luiz O Olivatto; Ivanir O Martins; Fabio P Lopasso
Journal:  J Surg Oncol       Date:  2012-11-05       Impact factor: 3.454

10.  Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.

Authors:  Laila Cunin; M Alfa-Wali; J Turner; M Bower; L Ion; T Allen-Mersh
Journal:  Ann Surg Oncol       Date:  2013-11-18       Impact factor: 5.344

View more
  2 in total

1.  Long-term results achieved by guideline-based stage-dependent management of anal cancer in a non-HIV population.

Authors:  Bernhard Fankhaenel; Joerg Zimmer; Dorothea Bleyl; Eric Puffer; Andreas Schreiber; Thomas Kittner; Helmut Witzigmann; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2019-10-22       Impact factor: 2.571

2.  Definitive chemoradiotherapy for anal canal cancer: single-center experience.

Authors:  Izumi Tachibana; Yasumasa Nishimura; Masahiro Inada; Kohei Fukuda; Kazuki Ishikawa; Tatsuyuki Nishikawa; Masaki Yokokawa; Kiyoshi Nakamatsu; Shuichi Kanamori; Jin-Ichi Hida
Journal:  Int J Clin Oncol       Date:  2018-07-10       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.